Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn's disease

被引:0
|
作者
Matar, M. [1 ,2 ]
Shamir, R. [1 ,2 ]
Turner, D. [3 ,4 ]
Broide, E. [5 ]
Weiss, B. [6 ]
Ledder, O. [3 ,4 ]
Guz-Mark, A. [1 ,2 ]
Rinawi, F. [1 ,2 ]
Cohen, S. [7 ]
Olivestone, C. Topf [8 ]
Shaul, R. [9 ]
Ben-Horin, S. [10 ]
Assa, A. [1 ,2 ]
机构
[1] Schneider Childrens Hosp, Petah Tiqwa, Israel
[2] Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
[3] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Jerusalem, Israel
[4] Juliet Keidan Inst Pediat Gastroenterol, Jerusalem, Israel
[5] Shamir Assaf Harofeh Med Ctr, Pediat Gastroenterol Unit, Zerifin, Israel
[6] Edmond & Lily Safra Childrens Hosp, Pediat Gastroenterol Unit, Ranat Gan, Israel
[7] Dana Dwek Childrens Hosp, Tel Aviv Sourasky Med Ctr, Pediat Gastroenterol Unit, Tel Aviv, Israel
[8] Kaplan Med Ctr, Pediat Gastroenterol Unit, Rehovot, Israel
[9] Rambam Med Ctr, Pediat Gastroenterol Unit, Haifa, Israel
[10] Sheba Med Ctr, Dept Gastroenterol, Ramat Gan, Israel
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P718
引用
收藏
页码:S578 / S579
页数:2
相关论文
共 50 条
  • [41] Induction and Maintenance Adalimumab Therapy for the Treatment of Moderate to Severe Crohn's Disease in Children
    Hyams, Jeffrey S.
    Griffiths, Anne M.
    Markowitz, James
    Baldassano, Robert
    Faubion, William A.
    Colletti, Richard B.
    Dubinsky, Maria
    Kierkus, Jaroslaw
    Wang, Yaqin
    Huang, Bidan
    Bittle, Barry
    Marshall, Michael
    Lazar, Andreas
    GASTROENTEROLOGY, 2011, 140 (05) : S90 - S90
  • [42] Pharmacokinetics of adalimumab in Crohn's disease
    Ternant, David
    Karmiris, Konstantinos
    Vermeire, Severine
    Desvignes, Celine
    Azzopardi, Nicolas
    Bejan-Angoulvant, Theodora
    van Assche, Gert
    Paintaud, Gilles
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (09) : 1155 - 1157
  • [43] Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn's Disease
    Xu, Lankai Cathy
    Grandhe, Sirisha
    Marsano, Joseph G.
    CASE REPORTS IN GASTROENTEROLOGY, 2022, 17 (01) : 143 - 147
  • [44] Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease
    Ribaldone, Davide Giuseppe
    Caviglia, Gian Paolo
    Abdulle, Amina
    Pellicano, Rinaldo
    Ditto, Maria Chiara
    Morino, Mario
    Fusaro, Enrico
    Saracco, Giorgio Maria
    Bugianesi, Elisabetta
    Astegiano, Marco
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [45] Miliary tuberculosis during adalimumab therapy in Crohn's disease
    Ameneiros-Lago, Eugenia
    Vazquez Bueno, Jose Angel
    Garrido Sanjuan, Juan Antonio
    MEDICINA CLINICA, 2018, 150 (10): : 412 - 412
  • [46] Comparison of Endoscopic Responses to Adalimumab Monotherapy and Combination Therapy With Azathioprine in Patients With Crohn's Disease: A Sub-Analysis of Diamond Trial
    Watanabe, Kenji
    Matsumoto, Takayuki
    Motoya, Satoshi
    Hisamatsu, Tadakazu
    Nakase, Hiroshi
    Yoshimura, Naoki
    Ishida, Tetsuya
    Kato, Shingo
    Nakagawa, Tomoo
    Nagahori, Masakazu
    Esaki, Motohiro
    Matsui, Toshiyuki
    Naito, Yuji
    Kanai, Takanori
    Suzuki, Yasuo
    Nojima, Masanori
    Watanabe, Mamoru
    Hibi, Toshifumi
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB250 - AB250
  • [47] Comparison of endoscopic responses to adalimumab monotherapy and combination therapy with azathioprine in patients with Crohn's disease: a sub-analysis of DIAMOND trial
    Watanabe, K.
    Matsumoto, T.
    Motoya, S.
    Hisamatsu, T.
    Nakase, H.
    Yoshimura, N.
    Ishida, T.
    Kato, S.
    Nakagawa, T.
    Nagahori, M.
    Esaki, M.
    Matsui, T.
    Naito, Y.
    Kanai, T.
    Suzuki, Y.
    Nojima, M.
    Watanabe, M.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S68 - S68
  • [48] Adalimumab maintenance therapy for patients with Crohn's Disease is cost effective compared with nonbiologic maintenance therapy
    Feagan, B.
    Loftus, E., Jr.
    Johnson, S.
    Wu, E.
    Yu, A.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S33 - S33
  • [49] Adalimumab mono vs. combination therapy in Crohn's Disease: Real world experience
    Babic, F.
    Cacic, P.
    Biscanin, A.
    Kralj, D.
    Kordej, D. Ogresta
    Dorosulic, Z.
    Hrabar, D.
    Tomasic, V
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1285 - i1285
  • [50] Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients
    Greener, Tomer
    Boland, Karen
    Milgrom, Raquel
    Ben-Bassat, Ofer
    Steinhart, A. Hillary
    Silverberg, Mark S.
    Narula, Neeraj
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (10) : 1274 - 1279